Variant report
Variant | nsv1024267 |
---|---|
Chromosome Location | chr8:9056355-9067942 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:16)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
(count:16 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060363 | XLOC_006705 |
2 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
3 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060364 | ENSG00000248538 |
4 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060347 | ENSG00000248538 |
5 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | NONHSAT124925 |
6 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | XLOC_006705 |
7 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
8 | lnc-RP11-10A14.4.1-2 | chr8:9056378-9056501 | NONHSAT124931 |
9 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060366 | XLOC_006705 |
10 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | XLOC_006705 |
11 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060368 | NONHSAT124925 |
12 | lnc-RP11-10A14.4.1-2 | chr8:9059902-9060357 | NONHSAT124931 |
13 | lnc-RP11-10A14.4.1-2 | chr8:9056378-9056501 | NONHSAT124930 |
14 | lnc-RP11-10A14.4.1-2 | chr8:9060009-9060357 | NONHSAT124930 |
15 | lnc-RP11-10A14.4.1-2 | chr8:9059902-9060000 | ENSG00000248538 |
16 | lnc-RP11-10A14.4.1-2 | chr8:9056434-9056501 | ENSG00000248538 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568695816 | chr8:9056357-9056358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187690529 | chr8:9056363-9056364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61744440 | chr8:9056409-9056410 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570247289 | chr8:9056422-9056423 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs2242280 | chr8:9056426-9056427 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs555813532 | chr8:9056454-9056455 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs141961550 | chr8:9056461-9056462 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs142715451 | chr8:9056466-9056467 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs192404691 | chr8:9056494-9056495 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs532676483 | chr8:9056512-9056513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138406291 | chr8:9056522-9056523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540300465 | chr8:9056526-9056527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372450599 | chr8:9056531-9056532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554189395 | chr8:9056591-9056592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577273531 | chr8:9056622-9056623 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374125168 | chr8:9056636-9056637 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566126973 | chr8:9056697-9056698 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562922422 | chr8:9056717-9056718 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200828616 | chr8:9056731-9056732 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377017260 | chr8:9056737-9056738 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369528388 | chr8:9056740-9056741 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562290723 | chr8:9056744-9056745 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs922705 | chr8:9056765-9056766 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs547651336 | chr8:9056767-9056768 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184620382 | chr8:9056769-9056770 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189240979 | chr8:9056799-9056800 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528730179 | chr8:9056804-9056805 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139966802 | chr8:9056816-9056817 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192696660 | chr8:9056864-9056865 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184303685 | chr8:9056895-9056896 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549141692 | chr8:9056900-9056901 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375836929 | chr8:9056945-9056946 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114714590 | chr8:9056955-9056956 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142192066 | chr8:9056956-9056957 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558053808 | chr8:9057000-9057001 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79013573 | chr8:9057072-9057073 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79122922 | chr8:9057091-9057092 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558273148 | chr8:9057105-9057106 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576477101 | chr8:9057110-9057111 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577931712 | chr8:9057123-9057124 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542085570 | chr8:9057153-9057154 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562323611 | chr8:9057170-9057171 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572519853 | chr8:9057174-9057175 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17654950 | chr8:9057175-9057176 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs188984621 | chr8:9057197-9057198 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532806395 | chr8:9057203-9057204 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568744452 | chr8:9057229-9057230 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549365295 | chr8:9057234-9057235 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373186586 | chr8:9057245-9057246 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536613411 | chr8:9057259-9057260 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9052400-9056600 | Weak transcription | Placenta | Placenta |
2 | chr8:9055000-9056400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr8:9055000-9056400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr8:9055000-9056400 | Enhancers | Fetal Heart | heart |
5 | chr8:9055400-9056600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:9055400-9057000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr8:9055400-9057000 | Enhancers | Ovary | ovary |
8 | chr8:9055800-9056600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr8:9056200-9056400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr8:9056200-9056600 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr8:9056200-9057000 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr8:9056200-9057000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:9056600-9058400 | Strong transcription | Placenta | Placenta |
14 | chr8:9056600-9064000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:9058400-9063000 | Weak transcription | Placenta | Placenta |
16 | chr8:9059600-9060000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr8:9059800-9061400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr8:9064000-9064800 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
19 | chr8:9064200-9064400 | Enhancers | H9 Cell Line | embryonic stem cell |
20 | chr8:9064400-9073600 | Weak transcription | H9 Cell Line | embryonic stem cell |
21 | chr8:9064800-9082400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
22 | chr8:9066000-9067400 | Enhancers | Fetal Intestine Large | intestine |
23 | chr8:9066200-9067000 | Enhancers | Fetal Intestine Small | intestine |
24 | chr8:9067600-9068200 | Enhancers | Fetal Brain Male | brain |
25 | chr8:9067800-9068000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
26 | chr8:9067800-9068200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |